Market Place
Sourcing Support
Illumina, Labcorp Expand Precision Oncology Testing Collaboration
18 Mar 2026 //
PR NEWSWIRE
Illumina Boosts Preventive Genomics With Veritas Genetics
16 Mar 2026 //
PR NEWSWIRE
Illumina Releases 2025 Q4 And Fiscal Year Financials
06 Feb 2026 //
PR NEWSWIRE
PacBio Completes Sale Of Short-Read Sequencing Assets
02 Feb 2026 //
GLOBENEWSWIRE
Standard Biotools Completes Sale Of Somalogic To Illumina
30 Jan 2026 //
GLOBENEWSWIRE
Illumina Reveals Preliminary Unaudited Financials For Q4 205
13 Jan 2026 //
PR NEWSWIRE
Illumina Hires Former NHGRI Director Eric Green As CMO
09 Jan 2026 //
FIERCE BIOTECH
Illumina & PREMIA Partner To Expand Clinical Access
08 Jan 2026 //
GLOBENEWSWIRE
Illumina Introduces Advanced Multiomic Analysis Software
06 Jan 2026 //
PR NEWSWIRE
Illumina To Webcast Upcoming Investor Conference
16 Dec 2025 //
PR NEWSWIRE
Illumina Releases Q3 Fiscal Year 2025 Financial Results
30 Oct 2025 //
PR NEWSWIRE
Angle PLC Reveals Interim Results
09 Sep 2025 //
ACCESSWIRE
Illumina to buy SomaLogic for $350M
23 Jun 2025 //
ENDPTS
PacBio Expands Reach in China with Clinical Distribution Deal
22 May 2025 //
FIERCE BIOTECH
EU Scraps Merger Power Aimed at Killer Acquisitions
29 Nov 2024 //
REUTERS
Illumina wins Grail battle in blow to EU merger power
03 Sep 2024 //
REUTERS
Cancer test maker Grail cuts 350 jobs as part of restructuring program
13 Aug 2024 //
REUTERS
Illumina Acquires Fluent BioSciences For Single-Cell Analysis Expansion
10 Jul 2024 //
FIERCE BIOTECH
Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2
27 Jun 2024 //
REUTERS
Grail bets big on flagship cancer test after spin-off from Illumina
25 Jun 2024 //
REUTERS
Integrated Bio: Illumina Venture For Novel Transcriptome Therapeutics
28 May 2024 //
BUSINESSWIRE
Illumina takes a step toward spinning off Grail, though keeps open for sale
06 May 2024 //
ENDPTS
EU approves Illumina`s plan to divest cancer test maker Grail
13 Apr 2024 //
REUTERS
Exclusive: Icahn drops Illumina board challenge threat, sources say
13 Mar 2024 //
REUTERS
Illumina forecasts flat 2024 sales as sluggish demand drags on
08 Feb 2024 //
REUTERS
Carl Icahn tries, again, to use secret info from Illumina board member
24 Jan 2024 //
REUTERS
Icahn ordered to remove lawsuit’s information that was supplied by Illumina
16 Jan 2024 //
ENDPTS
Illumina Ventures launches refreshed startup accelerator program
12 Jan 2024 //
FIERCE BIOTECH
Illumina reports stronger-than-expected growth
09 Jan 2024 //
ENDPTS
Activist Icahn prepares a second board challenge at Illumina -letter
18 Dec 2023 //
REUTERS
Illumina to divest Grail, two years after $8B deal was stymied
18 Dec 2023 //
ENDPTS
US court strikes down FTC order against Illumina`s purchase of Grail
15 Dec 2023 //
REUTERS
Illumina CFO says there`s outside interest in Grail as `outright sale` explored
28 Nov 2023 //
ENDPTS
Illumina cuts annual profit forecast for second straight quarter
09 Nov 2023 //
REUTERS
Veracyte Announces In Vitro Diagnostic Agreement with Illumina
07 Nov 2023 //
BUSINESSWIRE
Carl Icahn sues Illumina board members over Grail acquisition
18 Oct 2023 //
ENDPTS
Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus
30 Aug 2023 //
CONTRACT PHARMA
Illumina`s $7.1B Grail deal being investigated by SEC
10 Aug 2023 //
ENDPTS
EU orders Illumina to pay $476M fine over unapproved Grail deal
13 Jul 2023 //
ENDPTS
Illumina begins layoffs as part of $100M cost-cutting plan
27 Jun 2023 //
FIERCE BIOTECH
Illumina names Hologic CEO as new board member and chair
02 Jun 2023 //
ENDPTS
Illumina shareholders oust board chair, CEO survives Carl Icahn proxy battle
25 May 2023 //
CNBC
Illumina shareholders vote in one Icahn nominee over chairman
25 May 2023 //
FIERCE BIOTECH
Proxy adviser ISS supports only one of Icahn`s candidates for Illumina board
12 May 2023 //
ENDPTS
Ravgen settles patent fight with Illumina over genetic testing
17 Apr 2023 //
REUTERS
US FTC orders Illumina to divest cancer detection test maker Grail
03 Apr 2023 //
REUTERS
Icahn, Illumina privately discussed settlement before public fight - filing
30 Mar 2023 //
REUTERS
Illumina, Icahn trade jabs over Grail buy as proxy fight looms
20 Mar 2023 //
FIERCE BIOTECH
Illumina Ventures Announces Strategic New Additions to its Investment Team
24 Jan 2023 //
BUSINESSWIRE
As Illumina disappoints Wall Street, competitors make their case at JPM
11 Jan 2023 //
ENDPTS
Illumina defends $7.1 bln Grail buy to fend off antitrust regulators
13 Dec 2022 //
REUTERS
Illumina becomes the domino in layoffs trend, cutting around 5% of workforce
16 Nov 2022 //
ENDPTS
Illumina lays off 5% of employees as sales forecasts falter
15 Nov 2022 //
FIERCEBIOTECH
Glyn Edwards takes chairman role at UK oncolytic virus startup emerging out
26 Oct 2022 //
ENDPTS
Illumina, GenoScreen partner to expand access to genomic testing
19 Oct 2022 //
PHARMABIZ
Illumina Launches Collaboration with AZ to Accelerate Drug Target Discovery
12 Oct 2022 //
PRNEWSWIRE
Advocacy group look to comment on Illumina`s controversial Grail merger
06 Oct 2022 //
ENPTS
Illumina unveils revolutionary NovaSeq X series to rapidly genomic discoveries
01 Oct 2022 //
PHARMABIZ
Illumina pitches $200 genomes with new line of DNA sequencers
30 Sep 2022 //
FIERCEBIOTECH
Illumina Accelerator Invests in Funding Cycle of Startups Advancing Therapeutics
14 Sep 2022 //
PRNEWSWIRE
